ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibroblasts, Synovial"

  • Abstract Number: 1653 • ACR Convergence 2024

    Osteoarthritis Drives Inflammatory Imprinting of Synovial Fibroblasts, Exacerbating Gouty Arthritis Through m6A Modification of S100A4

    ZIYI CHEN1, Yinghui Hua2 and Wenjuan Wang1, 1Department of Sports Medicine, Huashan Hospital,Fudan University, Shanghai, Shanghai, China (People's Republic), 2Department of Sports Medicine, Huashan Hospital,Fudan University, Shanghai, China (People's Republic)

    Background/Purpose: Patients with osteoarthritis (OA) face an elevated risk of future gouty arthritis (GA). To delineate the underlying cellular and molecular mechanisms of OA-driven gout…
  • Abstract Number: 1661 • ACR Convergence 2024

    Rheumatoid Arthritis Synovial Fibroblast Modulation of T Cell Activation

    Melissa Romoff1, Daniel Ramirez2, Edward Dicarlo3, Susan Goodman4, Alexander Rudenska5, Laura Donlin1 and Melanie Smith1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Cartago, Costa Rica, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, New York 10025, NY, 5Memorial Sloan Kettering Cancer Center, New York, NY

    Background/Purpose: In the rheumatoid arthritis (RA) joint, resident synovial fibroblasts (FLS) interact with infiltrating leukocytes. We previously identified a population of sublining FLS responsive to…
  • Abstract Number: 1663 • ACR Convergence 2024

    Notch—mediated Fibrogenic Activation Is a Spatial Determinant of RA Treatment Response

    Kartik Bhamidipati1, Ce Gao1, Ksenia Anufrieva2, Shideh Kazerounian3, Roopa Madhu4, Miles Tran1, Vikram Khedgikar1, Sonia Presti1, Anna Helena Jonsson5, ilya Korsunsky1 and Kevin Wei6, 1Brigham and Women's Hospital, Boston, MA, 2BWH, Cambridge, MA, 3Brigham & Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Brookline, MA, 5University of Colorado School of Medicine, Aurora, CO, 6Brigham and Women's Hospital at Harvard Medical School, Boston, MA

    Background/Purpose: In RA, poor treatment response has been linked to a fibroid synovial tissue phenotype, characterized by lack of immune cell infiltration and an expansion…
  • Abstract Number: 0012 • ACR Convergence 2023

    Immune-cell Derived Cytokines Synergistically Interact to Drive Synovial Fibroblast Invasive Function and Metabolic Capacity

    Órla Tynan1, Achilleas Floudas2, Nuno Neto3, Michael Monaghan3, Siobhán Wade4, Dumitru Anton5, Carl Orr6, Douglas Veale7 and Ursula Fearon8, 1Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 2Dublin City University, Dublin, Ireland, 3Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland, 4Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 5Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 6EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 7St.Vincent's University Hosp, Dublin, Ireland, 8Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) encompass two of the most common forms of Inflammatory Arthritis. While common pathogenic mechanisms are involved in…
  • Abstract Number: 1753 • ACR Convergence 2023

    Acylcarnitine Enrichment Is a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint

    Georgios Vasileiadis1, Anna-Karin Hultgård Ekwall2, Reshmi Sureshkumar1, Monica Guma3, Anna Rudin4, Yuan Zhang1 and Cristina Maglio1, 1Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Kullavik, Sweden, 3San Diego VA Healthcare Service, La Jolla, CA, 4Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Several metabolic pathways have been implicated in rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) aggressive phenotype1,2. Here, we aimed to analyse the full spectrum of…
  • Abstract Number: 2503 • ACR Convergence 2023

    Cytokines Regulate the Fibrotic Response of Growth Factors in Joint Fibroblast-like Synoviocytes

    Sofie Falkenløve Madsen1, Mikkel Rathsach Andersen2, Alexander Scheller Madrid2, Signe Holm Nielsen3, Morten Karsdal3, Christian Thudium3 and Anne-Christine Bay-Jensen3, 1University of Copenhagen, Herlev, Denmark, 2Herlev-Gentofte Hospital, Gentofte, Denmark, 3Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) and osteoarthritis (OA) are characterized by inflammation, joint swelling, stiffness, and pain. A fibroid phenotype has been identified in RA, where…
  • Abstract Number: 0024 • ACR Convergence 2023

    Detection of Synovial Signatures in Peripheral Blood of Patients with Rheumatoid Arthritis via a Novel Blood-Based DNA Capture Assay

    Peter C. Taylor1, Jenya Antonova2, Jennifer Geis3, Katharine Dilger3, David Chernoff4, Diana Abdueva3, Nancy Shadick5 and Michael Weinblatt6, 1Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Compass Strategy and Research, Inc., San Francisco, CA, 3Aqtual Inc., Hayward, CA, 4Chernoff Consulting, Sausalito, CA, 5Brigham and Women's Hospital, Boston, MA, 6Harvard Medical School, Waban, MA

    Background/Purpose: In rheumatoid arthritis [RA], synovial biopsies were shown to guide therapy selection1. However, biopsies require special training for clinicians and are semi-invasive for patients.…
  • Abstract Number: 1755 • ACR Convergence 2023

    Unique Pattern of Cadherin 6 Localization in Fibroblast-Like Synoviocytes

    Camilla R. L. Machado1, David Boyle1, Narayanan B. Perumal2, Robert J. Benschop3 and Gary Firestein1, 1University of California San Diego, San Diego, CA, 2Eli Lilly and Company, San Diego, CA, 3Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: The synovial lining of rheumatoid arthritis (RA) is formed by a network of fibroblast-like synoviocytes (FLS). Cadherins are type I transmembrane proteins and participate…
  • Abstract Number: 2505 • ACR Convergence 2023

    Discovery of First-in-Class IRAK4 Scaffolding Inhibitors for the Treatment of Inflammatory Disorders

    Kate Byth1, Rodney Morgan2, Pierre Michelys3, Kellie Demock2, Geetha Kannan2, Qing Chen1, Brian Sanchez2, Xiaokang Lu2, Alissa Telling2, Chuck Lesch2, Carmen Yu2, Sarah Bradley2, Brian Andresen1, Sherif Hassanien2, Clarke Taylor2, Zhilin Hou2, Ken Borrelli1, Anna Gardberg1, Erika Munschy1, Adam Schwaid1, Anthony Opipari2, Shifeng Pan3 and Luigi Franchi2, 1Odyssey Therapeutics, Boston, MA, 2Odyssey Therapeutics, Ann Arbor, MI, 3Odyssey Therapeutics, San Diego, CA

    Background/Purpose: Interleukin-1 receptor-associated kinase 4 (IRAK4), is a key node that mediates inflammatory signaling in response to activation of toll-like receptor (TLR) and IL-1 receptor…
  • Abstract Number: 0041 • ACR Convergence 2023

    Interactions Between Synovial Fibroblasts and Macrophages: Implications for Tissue Remodeling in Chronic Inflammatory Diseases and Macrophage Differentiation in Response to the Immune Microenvironment

    Jia Li, Yanrong Cai, Xin Guan, Meike Ewald, Lars-Oliver Tykocinski, Hanns-Martin Lorenz and Theresa Tretter, Department of Internal Medicine V, Div. of Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

    Background/Purpose: Activated macrophages (Mph) can be subdivided in at least 2 major subgroups according to their polarization into classical pro-(M1-Mph) or anti-inflammatory (M2-Mph) subtypes. Together…
  • Abstract Number: 1760 • ACR Convergence 2023

    Methotrexate Augments the Release of Granulocyte-macrophage Colony-stimulating Factor from Activated Rheumatoid Arthritis Fibroblast-like Synoviocytes – Possible Consequences for Persistence of Joint Inflammation

    Beatrice Bergström1, Tilia Selldén1, Miriam Bollmann2, Mattias N.D Svensson1 and Anna-Karin Hultgård Ekwall3, 1University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 3University of Gothenburg, Kullavik, Sweden

    Background/Purpose: Activated fibroblast-like synoviocytes (FLS) are important mediators of synovitis and structural damage in rheumatoid arthritis (RA)[1]. Granulocyte-macrophage colony-stimulating factor (GM-CSF, encoded by the CSF2…
  • Abstract Number: 2506 • ACR Convergence 2023

    Role of TGF-β Activated Kinase 1 in Cytokine-Driven Juvenile Idiopathic Arthritis Synovial Fibroblasts Activation

    Meena Afroze Shanta1, Anil Singh2, Paul Panipinto3 and Salahuddin Ahmed2, 1College of Pharmacy and Pharmaceutical Science, Washington State University, Spokane, WA, 2Washington State university, Spokane, WA, 3Washington State University College of Pharmaceutical Science and Molecular Medicine, Spokane, WA

    Background/Purpose: Chronic synovitis is a debilitating manifestation of juvenile idiopathic arthritis (JIA). Synovial fibroblast is a major preparator of inflammatory arthritis and has not been…
  • Abstract Number: 0793 • ACR Convergence 2023

    The Dual Specificity Phosphatase 6 (DUSP6) Regulates Arthritis Severity and IL10 Production

    Teresina Laragione, Carolyn Harris, Natasha Rice and Percio Gulko, Icahn school of Medicine at Mount Sinai, New York, NY

    Background/Purpose: We have previously identified the Huntingtin-interacting protein-1 (HIP1) as a new gene implicated in the regulation of the rheumatoid arthritis (RA) fibroblast-like synoviocyte (FLS)…
  • Abstract Number: 1767 • ACR Convergence 2023

    TNF-α Utilizes the TWEAK/Fn-14 Axis in Human Rheumatoid Arthritis Synovial Fibroblasts to Induce Inflammation

    Farheen Sultan Shaikh1, Anil Singh1, Paul Panipinto2 and Salahuddin Ahmed1, 1Washington State University, Spokane, WA, 2Washington State University College of Pharmaceutical Science and Molecular Medicine, Spokane, WA

    Background/Purpose: Tumor necrosis factor-alpha (TNF)-α is a proinflammatory cytokine in rheumatoid arthritis that transduces intracellular signal transduction pathways through specific receptors, TNF-R1, and TNF-R2. The…
  • Abstract Number: 2507 • ACR Convergence 2023

    ZCCHC6 Modulates the Global Phosphorylation Landscape in TNF-a-induced Rheumatoid Arthritis Synovial Fibroblasts

    Anil Singh, Farheen Sultan Shaikh and Salahuddin Ahmed, Washington State university, Spokane, WA

    Background/Purpose: ZCCHC6, also known as TUT7 or TENT2, plays a crucial role in RNA processing and metabolism through its uridylyl transferase function. This function involves…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology